Thermopylae Holdings Ltd. - Jun 13, 2022 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
10%+ Owner
Signature
/s/ Tryn Stimart, attorney-in-fact
Stock symbol
ABCL
Transactions as of
Jun 13, 2022
Transactions value $
$514,908
Form type
4
Date filed
6/15/2022, 01:14 PM
Previous filing
Jun 8, 2022
Next filing
Aug 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Purchase $441K +54.9K +0.1% $8.03 55.6M Jun 13, 2022 Direct F1
transaction ABCL Common Shares Purchase $73.8K +9.17K +0.02% $8.05 55.6M Jun 14, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $7.99 to $8.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $8.045 to $8.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.